Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Ferguson

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Sex & Marital Therapy|March 20, 2002
Clinical trial development in female sexual dysfunctionDavid M Ferguson
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|February 10, 2021
Structural modeling and analysis of the SARS-CoV-2 cell entry inhibitor camostat bound to the trypsin-like protease TMPRSS2Diego E Escalante, David M Ferguson
Journal of Chemical Information and Modeling|March 28, 2006
Spectrophotometric determination and computational evaluation of the rates of hydrolysis of 9-amino-substituted acridinesJohn R Goodell, Bengt Svensson, David M Ferguson
Journal of Sex & Marital Therapy|January 12, 2010
Randomized, placebo-controlled, double-blind, parallel design trial of the efficacy and safety of Zestra in women with mixed desire/interest/arousal/orgasm disordersDavid M Ferguson, Balakrishna Hosmane, Julia R Heiman
The AAPS Journal|April 6, 2006
Molecular recognition of opioid receptor ligandsBrian E Kane, Bengt Svensson, David M Ferguson
Journal of Medicinal Chemistry|February 26, 2008
Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptorBrian E Kane, Christopher R McCurdy, David M Ferguson
Molecules (Basel, Switzerland)|May 14, 2022
Parameterization and Application of the General Amber Force Field to Model Fluoro Substituted Furanose Moieties and NucleosidesDiego E Escalante, Courtney C Aldrich, David M Ferguson
Journal of the American Chemical Society|April 25, 2002
Cation-pi interactions: an energy decomposition analysis and its implication in delta-opioid receptor-ligand bindingYirong Mo, Govindan Subramanian, Jiali Gao, et al.
Journal of Computer-Aided Molecular Design|September 30, 2006
A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonistNidhi Singh, Gwénaël Chevé, David M Ferguson, et al.
Bioorganic & Medicinal Chemistry|May 23, 2006
Synthesis and evaluation of acridine- and acridone-based anti-herpes agents with topoisomerase activityJohn R Goodell, Avni A Madhok, Hiroshi Hiasa, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Sex & Marital Therapy|March 20, 2002
Clinical trial development in female sexual dysfunctionDavid M Ferguson
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|February 10, 2021
Structural modeling and analysis of the SARS-CoV-2 cell entry inhibitor camostat bound to the trypsin-like protease TMPRSS2Diego E Escalante, David M Ferguson
Journal of Chemical Information and Modeling|March 28, 2006
Spectrophotometric determination and computational evaluation of the rates of hydrolysis of 9-amino-substituted acridinesJohn R Goodell, Bengt Svensson, David M Ferguson
Journal of Sex & Marital Therapy|January 12, 2010
Randomized, placebo-controlled, double-blind, parallel design trial of the efficacy and safety of Zestra in women with mixed desire/interest/arousal/orgasm disordersDavid M Ferguson, Balakrishna Hosmane, Julia R Heiman
The AAPS Journal|April 6, 2006
Molecular recognition of opioid receptor ligandsBrian E Kane, Bengt Svensson, David M Ferguson
Journal of Medicinal Chemistry|February 26, 2008
Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptorBrian E Kane, Christopher R McCurdy, David M Ferguson
Molecules (Basel, Switzerland)|May 14, 2022
Parameterization and Application of the General Amber Force Field to Model Fluoro Substituted Furanose Moieties and NucleosidesDiego E Escalante, Courtney C Aldrich, David M Ferguson
Journal of the American Chemical Society|April 25, 2002
Cation-pi interactions: an energy decomposition analysis and its implication in delta-opioid receptor-ligand bindingYirong Mo, Govindan Subramanian, Jiali Gao, et al.
Journal of Computer-Aided Molecular Design|September 30, 2006
A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonistNidhi Singh, Gwénaël Chevé, David M Ferguson, et al.
Bioorganic & Medicinal Chemistry|May 23, 2006
Synthesis and evaluation of acridine- and acridone-based anti-herpes agents with topoisomerase activityJohn R Goodell, Avni A Madhok, Hiroshi Hiasa, et al.
Pageof 5